PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for July 16, 2008 Subscribe to this News Feed    
 

Phenocal Gains Consumer Market Share On The Heels Of Alli

On the heels of these unpleasant Alli weight loss product reports, Phenocal, one of the leading OTC (over-the-counter) weight loss products on the market today that promises weight loss without the unsettling side effects, has seen a huge surge in sales by consumers looking for a weight loss alternative that promotes weight loss without interrupting the body's natural functioning.

(PRWEB) July 16, 2008 -- A year after Alli was marketed to the public, its maker GlaxoSmithKline (GSK), has reported a downward spiral in sales. When Alli first hit the market GSK reported $32 million in sales, which accounted for more than half of all the money made from the sales of over-the-counter weight-loss tablets. By the next month, sales slowed to $16 million. They continued to decline precipitously each month, reaching a low of less than $7 million at the end of December 2007. These declining sales were more than likely due to the word of mouth consumer reports who were finding some very unsettling side effects coupled with questionable success. Complaints of gas with oily spotting, loose stools and even uncontrollable explosive stools were reported by its users marking Alli as more of an "unpleasant side-effects" weight loss program rather than a results driven one. Many people add diet supplements to their new found healthy lifestyle's to help support and encourage their weight loss success.

On the heels of these unpleasant Alli reports, Phenocal, one of the leading OTC (over-the-counter) weight loss products on the market today that promises weight loss without the unsettling side effects, has seen a huge surge in sales by consumers looking for a weight loss alternative that promotes weight loss without interrupting the body's natural functioning. Consumers also found the 100% natural ingredients found in Phenocal to be a promising change to their digestive system.
"We know that being overweight has many adverse consequences, including an increase in the risk of obesity, heart disease, hypertension, and diabetes," said Cathy Russell, a spokesperson for Pharmaxa Labs, the U.S. manufacturer of Phenocal. "The unmatched effectiveness of the Phenocal product has put it in a class by itself. The consumers have spoken and they have opted for this product because it safe and it's effective. We are extremely fortunate that we have been able to positively impact people's health and lifestyles for the better."

Phenocal has a 3 part nutritional system that includes popular ingredients like Hoodia Gordonii, Green Tea leaf extract, Bioperine and Coleus Forskohlii which increases metabolism for faster results. Another promising benefit of Phenacol is its ability to absorb nutrients into the bloodstream. Experts believe that Bioperine can also boost the body's mechanism called thermogenesis or the ability to generate heat and burn calories instead of storing them as fat. Apart from that, Bioperine can also boost the digestive process, which can directly affect the efficiency or the rate of the body's metabolism and absorption of nutrients. It is also 100% natural so you won't experience harmful or even embarrassing side effects.

For more information on Phenocal™ and its safe and effective weight loss program visit www.Phenocal.com

###

OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Liz Gilman
800 344-0478
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.